Tundra Space

Tundra Space

Clinical Research Directory

Browse clinical research sites, groups, and studies.

Back to Studies
COMPLETED
NCT05481931

Non Interventional Safety Study of NUCEIVA for the Treatment of Moderate-to-Severe Glabellar Lines

Sponsor: Evolus, Inc.

View on ClinicalTrials.gov

Summary

Non-interventional PASS of NUCEIVA for the treatment of moderate-to-severe glabellar lines to provide additional characterisation of the long-term safety of NUCEIVA in the real-world clinical practice setting.

Official title: Non-Interventional Post-Authorisation Safety Study of NUCEIVA for the Treatment of Moderate-to-Severe Glabellar Lines

Key Details

Gender

All

Age Range

18 Years - 64 Years

Study Type

OBSERVATIONAL

Enrollment

756

Start Date

2023-03-15

Completion Date

2026-02-04

Last Updated

2026-05-14

Healthy Volunteers

Yes

Interventions

DRUG

prabotulinumtoxinA

Botulinum toxin Type A powder for solution for injection

Locations (1)

Cologne Dermatology

Cologne, Germany